Projects per year
Abstract
Background: Low grip strength and gait speed are associated with mortality. However, investigation of the additional mortality risk explained by these measures, over and above other factors, is limited. Aim: We examined whether grip strength and gait speed improve discriminative capacity for mortality over and above more readily obtainable clinical risk factors. Methods: Participants from the Health, Aging and Body Composition Study, Osteoporotic Fractures in Men Study, and the Hertfordshire Cohort Study were analysed. Appendicular lean mass (ALM) was ascertained using DXA; muscle strength by grip dynamometry; and usual gait speed over 2.4–6 m. Verified deaths were recorded. Associations between sarcopenia components and mortality were examined using Cox regression with cohort as a random effect; discriminative capacity was assessed using Harrell’s Concordance Index (C-index). Results: Mean (SD) age of participants (n = 8362) was 73.8(5.1) years; 5231(62.6%) died during a median follow-up time of 13.3 years. Grip strength (hazard ratio (95% CI) per SD decrease: 1.14 (1.10,1.19)) and gait speed (1.21 (1.17,1.26)), but not ALM index (1.01 (0.95,1.06)), were associated with mortality in mutually-adjusted models after accounting for age, sex, BMI, smoking status, alcohol consumption, physical activity, ethnicity, education, history of fractures and falls, femoral neck bone mineral density (BMD), self-rated health, cognitive function and number of comorbidities. However, a model containing only age and sex as exposures gave a C-index (95% CI) of 0.65(0.64,0.66), which only increased to 0.67(0.67,0.68) after inclusion of grip strength and gait speed. Conclusions: Grip strength and gait speed may generate only modest adjunctive risk information for mortality compared with other more readily obtainable risk factors.
Original language | English |
---|---|
Article number | 126 |
Journal | Aging Clinical and Experimental Research |
Volume | 36 |
Issue number | 1 |
DOIs | |
Publication status | Published - Dec 2024 |
Funding
Funders | Funder number |
---|---|
National Institute of Arthritis and Musculoskeletal and Skin Diseases | |
Axcella Health | |
National Institute for Health Research Southampton Biomedical Research Centre | |
Astellas Pharma US | |
U.S. Department of Agriculture | |
National Center for Advancing Translational Sciences | |
National Institutes of Health | U01 AG042139, R01AG028050, U01 AG042124, U01 AG042168, U01 AG042145, UL1 TR002369, U01 AG042143, U01 AG027810, U01 AG042140, R01 AG066671, U01 AR066160, N01AG62106, N01AG62101, N01AG62103 |
National Institutes of Health | |
Medical Research Council | MRC_MC_UP_A620_1014, MC_PC_21001, MC_PC_21003 |
Medical Research Council | |
National Institute of Nursing Research | R01NR012459 |
National Institute of Nursing Research | |
National Institute on Aging | R01AG027017, P30AG024827, K07AG033174, T32AG021885 |
National Institute on Aging |
Keywords
- Ageing
- Epidemiology
- Mortality
- Osteoporosis
- Sarcopenia
Fingerprint
Dive into the research topics of 'Predictive value of sarcopenia components for all-cause mortality: findings from population-based cohorts'. Together they form a unique fingerprint.Projects
- 1 Active
-
Clinical Pharmacology Research Group
Douxfils, J. (Supervisor), Dogné, J.-M. (Supervisor), Musuamba Tshinanu, F. (Supervisor), Masereel, B. (Supervisor), Wieërs, G. (Supervisor), Haguet, H. (Researcher), RONVAUX, L. (Researcher), Donis, N. (Researcher), Morimont, L. (Researcher), Evrard, J. (Researcher), Siriez, R. (Researcher), Gillot, C. (Researcher), FAVRESSE, J. (Researcher), BOUVY, C. (Researcher), Djokoto, H. (Researcher), Didembourg, M. (Researcher), David, C. (Support role), Melchionda, S. (Support role), Maloteau, V. (Technician), Boucher, A.-Y. (Technician), Devel, P. (Technician), Modaffari, E. (Technician), Vandeputte, M. (Technician), De Messemaeker, A. (Secretaire), Decarpentrie, J. (Researcher), Vassart, J. (Researcher) & De Groote, A. (Researcher)
1/04/22 → …
Project: Research Axis